| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Keros Therapeutics, Inc. | Director | Common Stock | 13,215 | $227,826 | $17.24 | 09 Mar 2026 | Direct |
| Lyell Immunopharma, Inc. | Chief Financial Officer | Common Stock | 15,306 | $161,386 | $10.54 | 21 Aug 2025 | Direct |
| Lyell Immunopharma, Inc. | Chief Financial Officer | Common Stock | 10,000 | $128,700 | $12.87 | 20 Aug 2025 | Co-grantor and Co-trustee |
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 12,050 | $47,357 | $3.93 | 10 Jun 2024 | Direct |
| 2seventy bio, Inc. | Director | Common Stock | 0 | $0 | $4.94 | 13 May 2025 | Direct |
| Coherus Oncology, Inc. | Director | Stock Option (Right to Buy) | 112,000 | 12 Jun 2025 | Direct | ||
| Lyell Immunopharma, Inc. | Chief Financial Officer | Option (right to buy) | 56,250 | 10 Feb 2025 | Direct | ||
| NOVAVAX INC | Director | Stock Option (Right to buy) | 42,840 | 25 Apr 2025 | Direct | ||
| NOVAVAX INC | Director | Restricted Stock Units | 28,560 | 25 Apr 2025 | Direct | ||
| Keros Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,788 | 09 Mar 2026 | Direct | ||
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 0 | 13 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 09 Mar 2026 | 2 | $0 | 4 | Director | 11 Mar 2026, 16:39 |
| KROS | Keros Therapeutics, Inc. | 09 Mar 2026 | 0 | $0 | 3 | Director | 11 Mar 2026, 16:37 |
| LYEL | Lyell Immunopharma, Inc. | 20 Aug 2025 | 2 | -$15,320 | 4 | Chief Financial Officer | 22 Aug 2025, 16:03 |
| LYEL | Lyell Immunopharma, Inc. | 11 Aug 2025 | 2 | -$2,785 | 4 | Chief Financial Officer | 13 Aug 2025, 21:06 |
| CHRS | Coherus Oncology, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 18:47 |
| TSVT | 2seventy bio, Inc. | 13 May 2025 | 4 | $0 | 4 | Director | 15 May 2025, 16:33 |
| NVAX | NOVAVAX INC | 25 Apr 2025 | 2 | $0 | 4 | Director | 29 Apr 2025, 08:08 |
| NVAX | NOVAVAX INC | 25 Apr 2025 | 0 | $0 | 3 | Director | 29 Apr 2025, 08:06 |
| LYEL | Lyell Immunopharma, Inc. | 17 Mar 2025 | 1 | +$111,620 | 4 | Chief Financial Officer | 18 Mar 2025, 19:01 |
| LYEL | Lyell Immunopharma, Inc. | 10 Feb 2025 | 3 | $0 | 4 | Chief Financial Officer | 26 Feb 2025, 19:29 |
| TSVT | 2seventy bio, Inc. | 10 Jun 2024 | 2 | $0 | 4 | Director | 12 Jun 2024, 18:52 |
| CHRS | Coherus BioSciences, Inc. | 03 Jun 2024 | 1 | $0 | 4 | Director | 05 Jun 2024, 18:52 |
| TSVT | 2seventy bio, Inc. | 20 Mar 2024 | 2 | $0 | 4 | Director | 25 Mar 2024, 16:28 |
| TSVT | 2seventy bio, Inc. | 20 Mar 2024 | 0 | $0 | 3 | Director | 25 Mar 2024, 16:27 |
| LYEL | Lyell Immunopharma, Inc. | 09 Feb 2024 | 2 | $0 | 4 | Chief Financial Officer | 13 Feb 2024, 20:19 |
| LYEL | Lyell Immunopharma, Inc. | 16 Nov 2023 | 8 | $0 | 4 | Chief Financial Officer | 20 Nov 2023, 20:55 |
| CHRS | Coherus BioSciences, Inc. | 07 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 16:56 |
| LYEL | Lyell Immunopharma, Inc. | 24 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 28 Feb 2023, 17:13 |
| CHRS | Coherus BioSciences, Inc. | 04 May 2022 | 1 | $0 | 4 | Director | 06 May 2022, 18:50 |
| CHRS | Coherus BioSciences, Inc. | 04 May 2022 | 0 | $0 | 3 | Director | 06 May 2022, 18:47 |
| CHRS | Coherus BioSciences, Inc. | 04 May 2022 | 0 | $0 | 3 | Director | 06 May 2022, 18:43 |
| LYEL | Lyell Immunopharma, Inc. | 16 Mar 2022 | 1 | $0 | 4 | Chief Financial Officer | 18 Mar 2022, 16:09 |
| LYEL | Lyell Immunopharma, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Chief Financial Officer | 16 Jun 2021, 19:21 |